(Rp)-8-pCPT-cGMPS, a novel cGMP-dependent protein kinase inhibitor

Braumann, 1985, Physico-chemical characterization of cyclic nucleotides by reversed-phase HPLC, J. Chromatogr., 350, 105, 10.1016/S0021-9673(01)93510-1

Butt, 1990, Inhibition of cGMP-dependent protein kinase by (Rp)-guanosine-3′,5′-monophosphorothioates, FEBS Lett., 263, 47, 10.1016/0014-5793(90)80702-K

Butt, 1992, Analysis of the functional role of cGMP-dependent protein kinase in intact human platelets using a specific activator 8-para-chlorophenylthio-cGMP, Biochem. Pharmacol., 43, 2591, 10.1016/0006-2952(92)90148-C

Corbin, 1986, Studies of cGMP analog specificity and function of the two intrasubunit binding sites of cGMP-dependent protein kinase, J. Biol. Chem., 261, 1208, 10.1016/S0021-9258(17)36077-5

Dostmann, 1990, Probing of the cyclic nucleotide binding sites of cAMP-dependent protein kinases I and II with analogs of adenosine 3′,5′-cyclic phosphorothioates, J. Biol. Chem., 265, 10484, 10.1016/S0021-9258(18)86973-3

Eigenthaler, 1992, Concentration and regulation of cyclic nucleotides, cyclic nucleotide-dependent protein knases and one of their major substrates in human platelets, Eur. J. Biochem., 205, 471, 10.1111/j.1432-1033.1992.tb16803.x

Genieser, 1988, Synthesis of nucleoside-3′,5′-cyclic phosphorothioates by cyclothiophosphorylation of unprotected nucleosides, Tetrahedron Lett., 29, 2803, 10.1016/0040-4039(88)85214-6

Halbrügge, 1990, Stoichiometric and reversible phosphorylation of a 46-kDa protein in human platelets in response to cGMP and cAMP-elevating vasodilators, J. Biol. Chem., 265, 3088, 10.1016/S0021-9258(19)39737-6

Kaczmarek, 1980, Microinjection of catalytic subunit of cyclic AMP-dependent protein kinase enhances calcium potentials of bag cell neurons in cell culture, 77, 748

Miller, 1973, Synthesis and biochemical studies of various 8-substituted derivatives of guanosine 3′,5′-cyclic phosphate, inosine 3′,5′-cyclic phosphate and xanthine 3′,5′-cyclic phosphate, Biochem. J., 12, 5310, 10.1021/bi00750a014

Ogreid, 1989, Comparisson of the two classes of binding sites (A and B) of type I and type II cyclic-AMP-dependent protein kinases by using cyclic nucleotide analogs, Eur. J. Biochem, 181, 19, 10.1111/j.1432-1033.1989.tb14689.x

Roskoski, 1983, Assays of protein kinase, Methods Enzymol., 99, 3, 10.1016/0076-6879(83)99034-1

Rothermel, 1983, Inhibition of glycogenolysis in isolated rat hepatocytes by the Rp-diastereomer of adenosine cyclic 3′,5′-phosphorothioate, J. Biol. Chem., 258, 12125, 10.1016/S0021-9258(17)44142-1

Sandberg, 1991, Characterization of Sp-5,6-dichloro-1-β-D-ribofuranosyl-benzimidazole-3′,5′-monophosphorothioate (Sp-5,6-DCl-cBiMPS) as a potent and specific activator of cyclic-AMP-dependent protein kinase in cell extracts and intact cells, Biochem. J., 279, 521, 10.1042/bj2790521

Walter, 1980, Immunological distinction between guanosine-3′,5′-monophosphate-dependent and adenosine-3′,5′-monophosphate-dependent protein kinase, J. Biol. Chem., 255, 3757, 10.1016/S0021-9258(19)85769-1